You can buy or sell Oragenics and other stocks, options, ETFs, and crypto commission-free!
Oragenics Inc., also called Oragenics, is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. Read More The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL. The listed name for OGEN is Oragenics Inc.
52 Week High
52 Week Low
— per share
Expected Nov 12, After Hours